Clinical Trials Browser

Phase 2 × Completed × letermovir × Clear all

NCT04017962 2025-08-11

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Phase 2 Completed

102 enrolled 13 charts

Cytomegalovirus Infections